To evaluate the effect of addition of an anionic surfactant on solid dispersion using model drug indomethacin

Drug Development and Industrial Pharmacy

Volumn 38, Issue 8, 2012, Pages 930-939

  Dave, Rutesh H ^a   Patel, Ashwinkumar D ^a   Donahue, Edward ^a   Patel, Hardikkumar H ^a  

^a LONG ISLAND UNIVERSITY   (United States)

Author keywords

Dissolution; SLS; Solid dispersion; Surfactant; Ternary solid dispersion

Indexed keywords

BUFFER; DODECYL SULFATE SODIUM; HYDROCHLORIC ACID; INDOMETACIN; PHOSPHATE; PLASDONE K29 32; POVIDONE; UNCLASSIFIED DRUG;

ARTICLE; CRITICAL MICELLE CONCENTRATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; INFRARED SPECTROSCOPY; MEASUREMENT; MEDICAL DEVICE; MODULATED DIFFERENTIAL SCANNING CALORIMETRY; SOLID; SPECTROPHOTOMETER; X RAY DIFFRACTION;

CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG COMPOUNDING; HYDROGEN-ION CONCENTRATION; INDOMETHACIN; MICELLES; POLYMERS; SODIUM DODECYL SULFATE; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SURFACE-ACTIVE AGENTS; TABLETS; WATER; X-RAY DIFFRACTION;

EID: 84863501906     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2011.633264     Document Type: Article

References (33)

1. Fujii M, Okada H, Shibata Y, Teramachi H, Kondoh M, Watanabe Y. (2005). Preparation, characterization, and tableting of a solid dispersion of indomethacin with crospovidone. Int J Pharm, 293:145-153.
2. Serajuddin AT. (1999). Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J Pharm Sci, 88:1058-1066.
3. Chiou WL, Riegelman S. (1971). Pharmaceutical applications of solid dispersion systems. J Pharm Sci, 60:1281-1302.
4. Leuner C, Dressman J. (2000). Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm, 50:47-60.
5. Tachibana T, Nakamura A. (1965). A method for preparing an aqueous colloidal dispersion of organic materials by using water-soluble polymers: Dispersion of Β-carotene by polyvinylpyrrolidone. Kolloid-Z Polym, 203:130-133.
6. Sekikawa H, Fukuda N, Takada M, Ohtani K, Arita T, Nakano M. (1983). Dissolution behavior and gastrointestinal absorption of dicumarol from solid dispersion systems of dicumarol-polyvinylpyrrolidone and dicumarol-β- cyclodextrin. Chem Pharm Bull, 31:1350-1356.
7. Ford JL. (1986). The current status of solid dispersions. Pharm Acta Helv, 61:69-88.
8. Sekikawa H, Nakano M, Arita T. (1978). Inhibitory Efect of Polyvinylpyrrolidone on the crystallization of drugs. Chem Pharm Bull, 26:118-126.
9. Yoshioka M, Hancock BC, Zograf G. (1995). Inhibition of indomethacin crystallization in poly(vinylpyrrolidone) coprecipitates. J Pharm Sci, 84:983-986.
10. Taylor LS, Zograf G. (1997). Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm Res, 14:1691-1698.
11. Mura P, Moyano JR, González-Rodríguez ML, Rabasco-Alvaréz AM, Cirri M, Maestrelli F. (2005). Characterization and dissolution properties of ketoprofen in binary and ternary solid dispersions with polyethylene glycol and surfactants. Drug Dev Ind Pharm, 31:425-434.
12. Gibaldi M, Feldman S, Wynn R, Weiner ND. (1968). Dissolution rates in surfactant solutions under stirred and static conditions. J Pharm Sci, 57:787-791.
13. Singh P, Desai SJ, Flanagan DR, Simonelli AP, Higuchi WI. (1968). Mechanistic study of the infuence of micelle solubilization and hydrodynamic factors on the dissolution rate of solid drugs. J Pharm Sci, 57:959-965.
14. Corrigan OI. (1985). Mechanism of dissolution of fast release solid dispersions. Drug Dev Ind Pharm, 11:697-724.
15. Fernandez J, Vila-Jato JL, Blanco J, Ford LJ. (1989). Some properties of Diazepam-polyethylene glycol 6000 solid dispersions and their modifcation in the presence of stearic acid and polysorbate 80. Drug Dev Ind Pharm, 15:2491-2513.
16. Sjkovist E, Nystrom C. (1988). Physicochemical aspects of drug release VI. Drug dissolution rate from solid particulate dispersions and the importance of carrier and drug particle properties. Int J Pharm, 47:51-66.
17. Sjkovist E, Nystrom C, Alden M. (1991). Physicochemical aspects of drug release XIII. The efect of sodium dodecyl sulfate additions on the structure and dissolution of a drug in solid dispersions. Int J Pharm, 69:53-62.
18. Pouton CW. (2006). Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classifcation system. Eur J Pharm Sci, 29:278-287.
19. Sjkovist E, Nystrom C, Alden M, Caram-Lehlam N. (1992). Physicochemical aspects of drug release. XIV. The efects of some ionic and non ionic surfactants on properties of a sparingly soluble drug in solid dispersions. Int J Pharm, 79: 123-133.
20. Wang X, Michoel A, Van den Mooter G. (2005). Solid state characteristics of ternary solid dispersions composed of PVP VA64, Myrj 52 and itraconazole. Int J Pharm, 303: 54-61.
21. Ismail S, Shawky S, Hafez E. (1987). A new approach for enhancing the dissolution rate of Phenacetin. Drug Dev Ind Pharm, 13:2147-2158.
22. Mallick S, Pattnaik S, Swain K, De PK. (2007). Current perspectives of solubilization: potential for improved bioavailability. Drug Dev Ind Pharm, 33:865-873.
23. Nasr HE, Gafar MS, Abdel-Kareem O, Abd El-Aziz F. (2010). Morphological, Rheological and Ultrasonic Characterizations of ECO-Friendly Microemulsion Lattices Based on Acrylate Monomers. J Am Sci, 6:897-910.
24. Sammour OA, Hammad MA, Zidan AS, Mowafy AG. (2011). QbD approach of rapid disintegrating tablets incorporating indomethacin solid dispersion. Pharm Dev Technol, 16:219-227.
25. Emara LH, Badr RM, Elbary AA. (2002). Improving the dissolution and bioavailability of nifedipine using solid dispersions and solubilizers. Drug Dev Ind Pharm, 28:795-807.
26. Valizadeh H, Nokhodchi A, Qarakhani N, Zakeri-Milani P, Azarmi S, Hassanzadeh D et al. (2004). Physicochemical characterization of solid dispersions of indomethacin with PEG 6000, Myrj 52, lactose, sorbitol, dextrin, and Eudragit E100. Drug Dev Ind Pharm, 30:303-317.
27. Karnachi A, De Hon R, Khan M. (1995). Compression of indomethacin coprecipitates with polymer mixtures: Efect of preparation methodology. Drug Dev Ind Pharm, 21:1473-1483.
28. Fini A, Cavallari C, Ospitali F. (2008). Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles. Eur J Pharm Biopharm, 70:409-420.
29. van Drooge DJ, Hinrichs WL, Frijlink HW. (2004). Anomalous dissolution behaviour of tablets prepared from sugar glass-based solid dispersions. J Control Release, 97:441-452.
30. de Waard H, Hinrichs WL, Visser MR, Bologna C, Frijlink HW. (2008). Unexpected diferences in dissolution behavior of tablets prepared from solid dispersions with a surfactant physically mixed or incorporated. Int J Pharm, 349:66-73.
31. Okonogi S, Puttipipatkhachorn S. (2006). Dissolution improvement of high drug-loaded solid dispersion. AAPS PharmSciTech, 7:E52.
32. Cheng Y, Ye X, Huang XD, Ma HR. (2006). Reentrant wetting transition on surfactant solution surfaces. J Chem Phys, 125:164709.
33. Bonnefond A, Paulis M, Leiza JR (2011). Kinetics of the emulsion copolymerization of MMA/BA in the presence of sodium montmorillonite. Appl Clay Sci, 51:110-116.